Aktienanalyse zu Exponent Inc (EXPO)EXPOExponent Inc

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $77.43 and a recent RSI of 91.863 indicating strong momentum. The company reported a 20.9% year-over-year revenue growth in Q2, reaching $171.61 million, which exceeded market expectations. Additionally, the forward P/E ratio is 31.55, suggesting reasonable valuation compared to its growth prospects. However, the main risk is the recent downgrade from UBS, lowering their price target to $72, which could indicate potential volatility ahead.

4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.